High Grade Endometrial Carcinoma — Trials

High Grade Endometrial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

63 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 9
Ph III recruiting: 2
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05390021	PET/MRI in Endometrial Cancer	withdrawn	N/A	0	Massachusetts General HospitalOTHER	0	Apr 2, 2024	clinicaltrials
NCT03836157	Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer	withdrawn	Phase 2	0	University of OklahomaOTHER	1	Jun 27, 2019	clinicaltrials